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Introduction: Adherence to glaucoma treatment is poor, potentially reducing therapeutic 
effects. A glaucoma educator was trained to use motivational interviewing (MI), a patient-
centered counseling style, to improve adherence. This study was designed to evaluate whether 
MI was feasible in a busy ophthalmology practice.
Methods: Feasibility was assessed using five criteria from the National Institutes of Health 
Behavior Change consortium: fidelity of intervention components to MI theory; success of the 
training process; delivery of MI-consistent interventions by the glaucoma educator; patient 
receipt of the intervention based on enrollment, attrition, and satisfaction; and patient enactment 
of changes in motivation and adherence over the course of the intervention.
Results: A treatment manual was designed by a multidisciplinary team with expertise 
in health psychology, public health, and ophthalmology. The glaucoma educator received 
6 hours of training including role-play exercises, self-study, and individual supervision. His 
MI-related knowledge and skills increased following training, and he delivered exclusively 
MI-consistent interventions in 66% of patient encounters. 86% (12/14) of eligible patients 
agreed to be randomized into glaucoma educator support or a control condition. All 8 patients 
assigned to the glaucoma educator completed at least 2 of 6 planned contacts, and 50% (4/8) 
completed all 6 contacts. Patients assigned to the glaucoma educator improved over time in 
both motivation and adherence.
Conclusion: The introduction of a glaucoma educator was feasible in a busy ophthalmology 
practice. Patients improved their adherence while participating in the glaucoma educator program, 
although this study was not designed to show a causal effect. The use of a glaucoma educator 
to improve glaucoma patients’ medication adherence may be feasible at other ophthalmology 
clinics, and can be implemented with a standardized training approach. Pilot data show the 
intervention can be implemented with fidelity, is acceptable to patients and providers, and has 
the potential to improve adherence.
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Introduction
Glaucoma is a leading cause of blindness worldwide.1,2 In the United States alone, over 
2 million people have glaucoma, and 130,000 are legally blind from this disease.3,4 
Unfortunately, medication nonadherence is an ongoing barrier to treatment. In one 
early study, glaucoma patients were just 42% adherent after being told they could go 
blind, and adherence improved only to 58% among patients who had already gone 
blind in one eye.5 Although medications have improved since that time with fewer 
doses per day and decreased systemic side effects, nonadherence to current glaucoma 
medications is still close to 50%.6Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Barriers to glaucoma treatment adherence include 
medication regimen characteristics, logistical issues like 
scheduling challenges, individual patient factors like memory 
problems, and poor doctor–patient communication. In a recent 
survey, 50% of ophthalmologists said that patients’ lack of 
motivation for treatment was a barrier to adherence, 55% said 
that medication cost reduced patients’ adherence, and 41% 
said that patients’ lack of knowledge about treatment was a 
primary barrier to adherence.7 However, studies of patients’ 
actual adherence behavior have found only a modest associa-
tion between treatment-related knowledge and adherence.8 
Patients’ negative attitudes toward treatment appear to be a 
more important determinant of nonadherence than lack of 
knowledge: patients who do not believe that nonadherence 
might lead to reduced vision are less likely to adhere to 
treatment, as are patients who report concerns about cost or 
trouble staying adherent while traveling.9 About one-third of 
glaucoma nonadherence is intentional, with patients being 
less likely to take medication if they see no need for it or 
are not concerned about the potential consequences of non-
adherence.10 Demographic and clinical variables including 
gender, marital status, geographic area, and treatment dura-
tion do not predict adherence.8 However, age, minority race/
ethnicity, and comorbid medical illness have been found to 
predict nonadherence in some studies.11
Motivational interviewing  
to improve medication adherence
Support and education from medical professionals can 
increase adherence.12 One model of provider-delivered sup-
port is motivational interviewing (MI), a counseling style 
focused on exploration and resolution of patients’ ambiva-
lence.13 Several meta-analytic reviews14,15 demonstrate MI’s 
utility for health behavior problems including nonadherence: 
It has been successfully used by primary care practitioners 
to promote healthy behaviors,16 by diabetes specialists to 
increase physical activity,17 and by dentists to improve oral 
health behaviors.18 In addition, nurse-delivered telephonic 
counseling using MI has been found to improve medication 
adherence for endometriosis,19 osteoporosis,20 serious and 
persistent mental illness,21 HIV ,22 and ulcerative colitis.23 
MI may be particularly helpful to patients from minority 
cultural groups.24
To our knowledge, MI has not been used in ophthalmol-
ogy practice, a setting that presents several challenges. First, 
glaucoma care traditionally has been conducted directly 
between physicians and patients, with little involvement of 
ancillary staff like nurses or care managers. However, patients 
and their ophthalmology providers may have different 
perceptions of adherence.18 Second, counseling techniques 
like MI are less familiar to ophthalmology practitioners than 
to those in other specialties, and require a communication 
style that is substantially different from ophthalmologists’ 
customary physician-directed approach.25 Third, patients 
may not be accustomed to receiving education or counseling 
from their ophthalmology providers. Finally, as in most care 
settings, lack of time and funding are barriers to change.26
Can MI be delivered by a glaucoma 
educator in ophthalmology 
practice?
This pilot study was designed to evaluate the feasibility of 
training a glaucoma educator to implement MI with patients 
at an outpatient ophthalmology practice. The rationale for 
adding a glaucoma educator was three-fold: (a) patients 
may benefit from extra time with a health care professional; 
(b) patients may feel more comfortable asking questions of 
an ancillary provider;27 and (c) educators can interact with 
patients using a style different from the traditional medical 
model.13 If MI delivered by a glaucoma educator improves 
adherence, this may also lead to reduced intraocular pressure, 
preservation of visual field, improved quality of life, delayed 
need for specialized or long-term care, and reduced overall 
health care costs. But because glaucoma educators and MI 
counseling are not currently part of ophthalmology practices, 
the feasibility of this approach must first be established.
Feasibility was evaluated using criteria from the NIH 
Behavior Change Consortium.28,29 This 5-level conceptualiza-
tion suggests that an intervention is translated to a new setting 
with high fidelity if it has adequate adherence to theory, if 
it is implemented successfully, delivered consistently by 
interventionists, and successfully received by patients, and 
if patients enact recommended changes in behavior.
Methods
Participants
Participants were recruited from the tertiary glaucoma clinic 
of one of the authors (MYK) at the Rocky Mountain Lions 
Eye Institute, Denver, CO in 2008. Physicians identified adult 
patients with primary or secondary open-angle glaucoma 
who were prescribed monotherapy topical glaucoma medi-
cation. Exclusion criteria were: patient-reported inability 
to administer eye drops, cognitive impairment, physician’s 
determination that glaucoma surgery was likely within 
6 months, or .80% adherence during a 2-month run-in 
phase. Eligible patients were randomized to receive either Clinical Ophthalmology 2010:4
51 patients 
consented and
started run-in phase 
12 participants 
randomized to study
groups
37 participants excluded from further 
study due to adherence ≥80%;
2 did not agree to be randomized 
4 participants 
assigned to usual-care
control group (data
not reported here)
8 participants 
randomly assigned to
glaucoma educator
condition
4 participants 
completed 14 weeks
of follow-up 
4 participants dropped out before 
completing 6 months of glaucoma educator
intervention: 3 African-American participants
(out of 4) and 1 white non-Hispanic participant
(out of 4) dropped out 
Figure 1 Study recruitment and participant flow.
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standard glaucoma care or standard care plus glaucoma 
educator counseling. Patients did not receive any incentives 
for participating in the study.
Fifty-one patients consented, and 14 were ,80% adherent. 
The high rate of adherence in 73% (37/51) of screened patients 
may have resulted from adherence monitoring during the run-in 
phase. Twelve of these patients consented to be randomized, 
and 8 were assigned to the glaucoma educator intervention. 
Patient recruitment and study flow are shown in Figure 1.
Procedure
This study was approved by the Colorado Multiple Institu-
tional Review Board, and participants gave written informed 
consent. On average, 35–40 patients were seen per half 
day of clinic during the recruitment period. Patients were 
approached to participate by their ophthalmologist and those 
who agreed were escorted by the clinic study coordinator to 
a research examination lane where the consent process was 
completed. During the run-in phase and intervention, partici-
pants stored their medication eye-dropper in a bottle with a 
Medication Event Monitoring System (MEMS) cap. MEMS 
caps are electronic devices that record the time and date a pill 
bottle is opened. Bottles with MEMS caps accommodate all 
currently used glaucoma eye drops. Patients were given the 
MEMS bottle by the clinic study coordinator at the time they 
provided informed consent, and they returned to the clinic 
for a second meeting with the study coordinator at the end of 
the 2-month run-in period to determine baseline adherence Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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and study eligibility. Eligible patients randomized to the 
glaucoma educator condition were then scheduled for their 
initial educator visit at a later date. The glaucoma educator 
had no previous contact with any of the study participants. 
MEMS data were also downloaded and analyzed at each 
in-person glaucoma educator visit. Participants were aware 
that MEMS were being used to monitor their medication 
use. The long run-in period was designed to ensure that any 
improvements in adherence due to MEMS use occurred prior 
to the glaucoma educator intervention so that any further 
improvements in adherence would be attributable to the MI 
intervention.
Participants assigned to the glaucoma educator were 
scheduled to receive three one-to-one meetings with the 
glaucoma educator and three phone calls. Each included a 
review of the participant’s current adherence, barriers to tak-
ing medication, side effects, and questions about treatment. 
The glaucoma educator was trained to recognize and address 
habits, beliefs, and emotions that interfere with adherence, 
and to respond within an MI counseling framework.19 To rein-
force teaching points, the educator distributed print material 
approved by the American Academy of Ophthalmology.
The first glaucoma educator session was scheduled within 
1 week after randomization. Follow-up calls were scheduled 
1, 6, and 14 weeks later, with in-person meetings scheduled 
4 and 12 weeks post-randomization. Patients continued to 
receive care from their ophthalmologists, who were masked 
to patients’ group assignment.
Measures
Theory fidelity
MI is based on four principles, summarized in Table 1: 
express empathy, roll with resistance, develop discrepancy, 
and support self-efficacy.30 These principles define an 
empathic counseling style focused on listening carefully to 
individual patients’ concerns, increasing patients’ awareness 
about unintended consequences of behavior, avoiding argu-
ment or lecturing, and encouraging patients to develop their 
own solutions and make informed decisions about adherence. 
The empathic and directive “spirit” of MI is more important 
than specific counselor behaviors.31 A manual and counselor 
tools were developed for this intervention, and their fidelity to 
MI theory was evaluated by multidisciplinary expert review. 
The educator’s feedback was also obtained.
glaucoma educator training
The training process was documented, including the glaucoma 
educator’s prior counseling experience, training received, 
and follow-up consultation. The educator’s knowledge and 
comfort with the intervention were assessed using standard-
ized educational evaluation tools.32
implementation of Mi
Implementation was documented using a session record 
form developed for this study. Session length and number of 
contacts were recorded. The glaucoma educator also reported 
his use of MI techniques, participants’ current adherence, any 
barriers identified, and participants’ readiness for change.
Patient receipt of Mi
Receipt is the degree to which patients receive the intervention 
as designed. Receipt was evaluated based on eligible patients’ 
participation and attrition from the program over time.
Patient enactment
Enactment is the degree to which participants take necessary 
follow-up steps, such as increasing motivation or changing 
behavior. Motivation was assessed at each session via a stage-
of-change rating33 by the glaucoma educator, coded numeri-
cally on a 1–4 scale with 1 indicating the lowest readiness for 
change and 4 the highest. Adherence was based on MEMS 
data, which are widely regarded as valid,34 do not have a 
strong direct effect on patients’ medication-taking behavior,35 
and have been used in glaucoma research.7,28,29 Although 
MEMS data are considered as close to a “gold standard” as 
exists in the science of medication adherence, using multiple 
measures is always preferred36 because MEMS record only 
the first step in using medication (opening the bottle) rather 
than an actual attempt to administer the medication or verifi-
cation that eye drops were administered correctly. Therefore, 
MEMS data were supplemented with a clinical interview 
measure that has shown .70% agreement with pharmacy 
data.20 For both measures, adherence was defined as the 
percentage of days since the last session on which medica-
tion was taken as prescribed, based on the number of doses 
taken but not on the specific timing of doses. This adherence 
metric was selected to keep the two measures comparable, 
and to minimize recall bias in patient reports.
Data analysis
Analyses were primarily descriptive statistics, calculated 
using SPSS software (v. 17; SPSS, Inc., Chicago, IL, USA). 
For patient enactment measures, the multilevel modeling 
program HLM 6.03 (Scientific Software International Inc., 
Lincolnwood, IL) was used to evaluate within-patient changes 
in motivation and behavior over time.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Results
Results for the five dimensions of treatment fidelity are sum-
marized in Table 2.
Theory fidelity
The authors created an intervention manual with informa-
tion about why traditional patient education is ineffective, 
basic MI strategies (eg, open-ended questions, acceptance, 
reflection, and summarizing), the “ask-tell-ask” method of 
patient education, additional techniques for patients who 
appear “resistant” to change, and problem-solving strategies 
for more motivated patients. A form was also developed to 
document counseling sessions.
The manual and session record form were reviewed 
by experts in health psychology, public health, and 
ophthalmology. Additional feedback was obtained from 
three colleagues with expertise in MI, each of whom has 
a terminal degree in nursing or social work and at least 
5 years of clinical experience in health behavior change. 
All components were viewed as being consistent with 
the theory of behavior change underlying MI.24 Sugges-
tions incorporated from this review focused on address-
ing logistical barriers to adherence and changes in the 
exact wording of interventions. Additional feedback was 
requested from the glaucoma educator, who requested 
further information about cultural competence and mental 
health issues that might interfere with adherence. These 
topics were incorporated into an additional training session 
and practice exercises.
glaucoma educator training
The glaucoma educator was a certified ophthalmic technician 
with over 12 years of clinical experience. He completed 
training with two ophthalmologists on glaucoma drops and 
their side effects. He then reviewed the intervention manual 
and completed in-person training with one of the authors 
(PFC), a psychologist with expertise in health behavior 
change. Training included discussion of the manual, role-play-
ing patient scenarios, and individual consultation to discuss 
the first few patients seen. Training that includes face-to-face 
instruction plus supervised practice over time is more effica-
cious than single-day workshops or self-study alone.37
At the start of training, the educator had excellent inter-
personal skills and some patient education experience, but no 
experience using MI. By the end of training, he almost exclu-
sively used MI-consistent techniques during role-play and 
always elicited the patient’s knowledge and reactions before 
offering educational messages. The trainer’s ratings of the 
educator’s MI skills reflected this improvement. In addition, 
the educator’s self-assessed knowledge of MI, willingness to 
use MI, and reported use of eight MI-consistent techniques 
each increased from pre- to post-training.
implementation of Mi
Based on the session record form, the counselor used 
MI-consistent listening techniques 100% of the time. For 
patients with low readiness for change, all 13 counseling 
sessions involved elicitation, reflection, and summariza-
tion of participant responses, and 10 also included patient     
Table 1 Motivational interviewing (Mi) counseling style
MI principle Sample communication techniques
express empathy — Use open-ended rather than yes/no questions (“how are you doing with this medication?”) 
— Reflect back the patient’s statements (“I hear you saying …”)
—   Validate the patient’s concerns (“a lot of people have trouble taking their medication exactly as  
it’s prescribed …”)
roll with resistance — Don’t argue (“I apologize; I wasn’t trying to lecture you”) 
— Reflect back emotions (“it sounds like you feel stuck”) 
—   Ask about the patient’s experience (“what have you heard about this medication?” “are there 
people in your family who had similar experiences?” “what have you tried so far?”)
Develop discrepancy — Empathize with ambivalence (“you want to, and it’s also hard”) 
—   Highlight areas of contradiction (“there are things you don’t like about treatment, but you also 
see some benefits”) 
—   Summarize problems and strengths together (“you’ve had trouble remembering medication, but 
you are able to juggle many other things in your life successfully”)
Support self-efficacy — Emphasize autonomy (“this is really your decision”) 
—   educate using “ask-tell-ask” rather than “tell-ask-tell” (“how do you usually take your medication? 
Can i tell you a little more about the way it works? The medication only stays active for a certain 
length of time, so it’s very important to use the drops exactly 12 hours apart to get the desired 
benefits. What do you think of what I just told you?”) 
— Ask the patient to make choices (“what would you like to do now? Where do we go from here?”)Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Table 2 Treatment fidelity of motivational interviewing (MI) in outpatient glaucoma care
Criteria Fidelity measures Results
Theory fidelity 1.   expert review by co-authors and three colleagues  
with Mi expertise
2. Feedback from glaucoma educator
1 & 2. suggestions led to new material on logistical 
barriers to adherence, cultural competence, and mental 
health issues, plus some changes in the exact wording of 
interventions
educator training 1.   Amount of training provided 
2.   Trainer rating of educator’s MI skill on a 1–10 scale  
(1 = no experience; 4 = novice; 7 = skilled;  
and 10 = expert)
3.   Educator’s ratings on Likert-type scales  
(1 = low to 5 = high): knowledge, Mi skills,  
and willingness to use Mi
1.   Training included 5.5 hours self-study + 6 hours in-person 
with role-plays 
2.   Trainer’s ratings: educator’s MI skill at start of 
training = 3, Mi skill after training = 7 
3.   Educator’s ratings: increase in knowledge (pre = 1.5, 
post = 4.5), Mi skills (pre = 1.3, post = 2.5), and 
willingness (pre = 1.3, post = 4.0)
implementation 1.   Counselor’s use of MI-consistent interventions,  
as documented on session record form.  
interventions were considered Mi-consistent 
if they matched the patient’s counselor-rated 
stage of readiness for change
1.   For patients with low readiness: 13/13 sessions used 
active listening alone (Mi-consistent), 10/13 also used 
problem-solving (Mi-inconsistent). For patients with 
high readiness: 11/16 sessions used active listening, 2/16 
education plus listening, and 3/16 problem-solving plus 
listening (all Mi-consistent)
receipt 1.   enrollment 
2. Attrition 
3.   representativeness of participating  
patients
1.   12/14 eligible patients consented 
2.   8/8 patients completed 2+ sessions; 4/8 patients 
completed all 6 sessions 
3.   4 participants (50%) were male, and 4 (50%) were white 
non-hispanic; clinic patients overall were 38% male and 
78% white non-hispanic
enactment 1.   Change in motivation, based on a 1–4  
stage-of-change scale 
2.   Change in % adherence, based on MeMs  
and clinical interview measures
1.   Motivation increased with more sessions, T = 1.98, 
P = 0.058, β = 0.15 
2.    Adherence increased based on MeMs, T = 2.25, P = 0.032, 
β = 2.68, but not based on clinical interview, T = 1.07, 
P = 0.30, β = 1.03.
education (considered MI-consistent as long as it was offered 
together with active listening techniques). However, 10 of 
these 13 sessions also involved active problem solving, which 
was considered an MI-inconsistent technique for this patient 
group. With patients who had higher readiness for change, 11 
of 16 sessions involved listening alone, 2 involved listening 
with education, and 3 involved listening with both education 
and action-oriented strategies, all of which were considered 
MI-consistent. Overall, the educator used MI-consistent 
techniques in all sessions, and used exclusively MI-consistent 
techniques in 19/29 sessions (66%).
Patient receipt of Mi
Of 14 eligible patients, 12 (77%) agreed to be randomized; the 
two patients who did not agree were both African-American 
women, one aged 57 years and one over 80 years. Patients 
in the glaucoma educator condition had an average age of   
57.9 years (standard deviation [SD] = 8.5), and 4 (50%) 
were male. Participants were 50% (4) white non-Hispanic 
and 50% (4) African-American. The demographics of the 
four patients randomly assigned to the control condition 
were similarly diverse: these participants had an average 
age of 55.5 years (SD = 14.7), 3 (75%) were male, and only 
1 (25%) was white, with one Asian, one African-American, 
and one Pacific Islander participant in the control group. 
The demographics of patients randomly assigned to the 
glaucoma educator were more diverse than the total clinic 
population, where patients were 38% male and 78% white 
non-Hispanic. It is not known why the sample included more 
men and African-American patients, as these groups were 
not specifically targeted for recruitment. However, this find-
ing does suggest that the glaucoma educator intervention 
was acceptable to a diverse patient group. Participants were 
selected specifically for nonadherence, which may be cor-
related with nonwhite race/ethnicity. Baseline nonadherence 
was high both for patients randomly assigned to the glau-
coma educator (MEMS-based nonadherence on M = 36.7% 
of days per week, SD = 18.5) and for those assigned to the 
control condition (nonadherence on M = 37.0% of days per 
week, SD = 12.9).
The acceptability of MI to patients is illustrated by the 
following case vignette:
Mr S was a 52-year-old African-American man. His base-
line adherence was 61%, and when offered a chance to speak Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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with the glaucoma educator, he said he appreciated someone 
taking time to answer his questions. Mr S assumed he needed 
to take his medication “at bedtime,” which varied widely 
from day to day. Mr S also said that he was often tired and 
forgot to use his drops at night. The glaucoma educator used 
the “ask-tell-ask” method to teach Mr S about the importance 
of dosing every 24 hours, and that the time of day was flex-
ible. Mr S expressed frustration that no one had explained 
this to him before, and the glaucoma educator validated Mr 
S’s desire to manage his own treatment more effectively. 
Mr S offered his own solution of taking medication at 8 pm 
as opposed to “at bedtime.” Further contacts helped Mr S to 
maintain this static time strategy and to overcome difficulties 
with forgetting. Based on these changes, Mr S improved his 
adherence to 95% by the end of 3 months of contact with 
the glaucoma educator. Mr S said he was very satisfied with 
the new therapeutic dosing regimen and with the assistance 
he received from the educator.
Of the eight patients randomly assigned to the glaucoma 
educator, all eight completed at least two sessions. On aver-
age, participants received 4.5 (SD = 1.85, 95% confidence 
interval [CI]: 2.95, 6.05) of six planned contacts, including 
2.25 (SD = 0.89) in-person and 2.0 (SD = 0.93) telephone 
contacts. In-person sessions lasted 30–45 minutes, and 
telephone sessions lasted 5–10 minutes. Attrition was 4/8 
(50%) over 6 months. Older patients were more likely to 
attrit, r = 0.52, and more African-American (75%) than 
white participants (25%) did not complete the full 6-month 
intervention. Two of the four participants who dropped out 
stated that they were unwilling to make further study-related 
clinic visits in the absence of incentives, and the other two 
participants were lost to follow-up due to a lack of stable 
contact information – both of these patients had disconnected 
phones and also failed to return for usual care. In one case, 
the participant was sent a registered letter, which was also 
not received. However, no participants reported any adverse 
events, and no patients withdrew specifically because they 
were dissatisfied with the intervention.
Patient enactment
Patient behavior was analyzed using an intent-to-treat 
method, with all patients in the glaucoma educator condition 
included in analyses regardless of how many sessions they 
completed. Participants’ readiness for change and two mea-
sures of adherence were modeled as separate outcomes, each 
analyzed within persons based on the number of glaucoma 
educator sessions completed. Models corrected for moderate 
to high inter-correlation of data points within participants, 
intraclass correlation (ICC) = 0.49 for readiness, ICC = 0.75 
for counselor-rated adherence, and ICC = 0.77 for MEMS-
based adherence. Effects are reported as unstandardized betas 
on a 1–4 scale for readiness, and as 0–100 percentages for the 
two adherence measures. As shown in Table 1, participants’ 
readiness for change increased as more educator visits were 
completed. Participants’ adherence improved significantly 
over time based on MEMS data, with no significant change 
in counselor-rated adherence. MEMS are likely the more 
accurate measure, as counselor-rated adherence was initially 
higher and may have been biased by a ceiling effect due to 
inaccurate patient reporting of adherence.
Patient enactment of behavior change is illustrated by the 
following case vignette:
Ms D was a 60-year-old white female. Her baseline 
adherence was 75%, which she was surprised to learn dur-
ing her first visit with the glaucoma educator. When asked 
how she felt about her current adherence, Ms D said she was 
disappointed, and that difficulty using her eye drops and for-
getfulness were the primary reasons for her poor adherence. 
The glaucoma educator responded by asking about Ms D’s 
goals and past experiences. Ms D noted that she did take other 
medications successfully, even when traveling. She set a goal 
of .85% adherence for herself, and suggested that using eye 
drops at the same time as her other evening medications might 
help her to remember them. The glaucoma educator agreed 
to a test of this plan. Over 3 months of follow-up contact, 
the glaucoma educator also helped Ms D problem-solve dif-
ficulties in administering eye drops by finding a technique 
that worked for her. Ms D was able to improve her adher-
ence to 100% by the end of the program. Over time, it also 
emerged that Ms D had not strongly believed treatment was 
beneficial; the glaucoma educator helped her to explore this 
ambivalence, and by the conclusion of the program Ms D 
said that conversations with the educator had helped her to 
see the importance of taking medication correctly.
Discussion
Medication nonadherence is a barrier to successful glaucoma 
treatment that is not systematically addressed in most oph-
thalmology practices. The current study demonstrated that 
an in-person and telephone glaucoma educator intervention 
was feasible for implementing MI, a research-based health 
behavior change counseling technique, in a busy ophthal-
mology practice. Using an intervention manual and clinical 
support tools developed by a multidisciplinary expert group, 
a glaucoma educator was trained to implement MI with 
nonadherent patients. The educator had no initial exposure Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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to MI, but reported that the method was relatively easy to 
learn. After individual training and self-study, his self- and 
instructor-rated competence with these methods improved 
from novice to skilled. Session rating forms showed that all 
of his interventions used MI-consistent techniques, but that he 
over-used problem-solving techniques with participants who 
were not yet ready for change. This is a common issue among 
providers new to MI, and additional training on matching 
techniques to patients’ readiness for change might improve 
these results. However, research also shows that multiple 
counselor behaviors may be appropriate, as long as they are 
delivered in the patient-centered “spirit” of MI.31
Ophthalmology patients were willing to participate in 
the educator intervention. Participants’ demographics were 
more diverse than the overall population served by this 
clinic, indicating that the intervention was acceptable to a 
broad range of glaucoma patients. Half of patients dropped 
out early, so attrition was a significant limitation to MI’s 
feasibility in this study. The requirement of ,80% baseline 
adherence may have resulted in a particularly nonadherent 
sample who were more difficult to retain over time. Two of 
the four participants lost to follow-up had their phone num-
bers disconnected and left care completely at the time they 
dropped out of the study. Although 50% attrition over six 
planned contacts is not unusual for psychosocial interven-
tions,38 it was considered quite high for this ophthalmology 
practice. Despite the high attrition rate, all participants 
received at least two of six planned contacts, which was 
considered an adequate dose of the intervention because 
even brief MI is efficacious.14
Given that the intervention was successfully implemented 
and acceptable to patients, a final question is whether partici-
pants were able to enact recommended changes. Participants 
showed nonsignificant improvement in readiness for change 
and significant improvement in MEMS-based adherence 
over the course of the intervention, although there was no 
change on counselor-rated adherence. Whether these changes 
represented improvements over standard care is an efficacy 
question not addressed in the current study.
Potential challenges to widespread adoption of the 
glaucoma educator intervention in ophthalmology practice 
include staffing the educator position and integrating behav-
ior change techniques with other aspects of medical care. 
Although in this study ophthalmologists were masked to the 
educator intervention, in actual practice the educator would 
be in regular contact with the patient’s ophthalmologist. 
This might enhance benefits of the intervention due to better 
coordination of care, or might reduce its effects if patients 
are less honest or less able to develop a working relationship 
with the glaucoma educator.
Cost of the educator position is another potential con-
cern. However, if a glaucoma educator improves adherence 
and reduces long-term costs (eg, due to reduced vision loss, 
hospitalization, or need for long-term care), then a case could 
be made to insurers and other stakeholders that this service 
should be reimbursed. Health and behavior CPT codes 
exist to categorize patient counseling for chronic disease 
self-management, so an effective billing mechanism is not 
the issue, only whether adherence counseling should be a 
covered benefit. Cost-effectiveness analyses are therefore 
an important focus for future work.
Limitations and directions  
for future research
This study found that a glaucoma educator intervention was 
feasible in one outpatient ophthalmology practice. A small 
sample size and single clinic setting are important limita-
tions to the generalizability of results. The two participat-
ing ophthalmologists were already aware of the problem 
of glaucoma medication nonadherence and committed to 
finding solutions. Implementation may be more difficult in 
settings where ophthalmologists are less aware of or inter-
ested in addressing nonadherence. Results showed that a 
newly trained glaucoma educator was relatively successful 
in delivering MI-consistent interventions although he also 
delivered some MI-inconsistent interventions. Conclusions 
about the actual content of glaucoma educator interventions 
would be strengthened in future studies by incorporating an 
independent expert’s ratings of session tapes or transcripts 
using an objective behavioral coding system such as the 
Motivational Interviewing Skills Code,39 in addition to the 
glaucoma educator’s report.
Measurement is a universally acknowledged limitation 
in adherence studies, and the current investigation was no 
exception. The use of multiple measures is recommended 
because there is no “gold standard” for adherence.36 
Although we used two independent measures of adherence 
– MEMS and clinical interview – that have each been used 
in past research and are supported by psychometric data, the 
two measures did not always agree. In our study, adherence 
based on MEMS tended to be lower than educator-rated 
adherence. This may in part explain the finding that adher-
ence improved based on MEMS data only, because MEMS-
based adherence had more room to improve. This finding also 
highlights health care providers’ challenges in making accu-
rate judgments about adherence: Recent research suggests Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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that ophthalmologists detect nonadherence in less than 30% 
of cases where the patient is actually nonadherent.25 Both 
adherence measures in this study assessed only the percent-
age of days on which patients took the correct number of 
doses; because glaucoma medications have short half-lives 
and the timing of doses is also important, more fine-grained 
MEMS-based adherence measures of dose timing may be 
desirable in future research.
Although participants were aware that MEMS were 
being used to monitor their adherence, research in other 
fields suggests that participants are more likely to misrepre-
sent their adherence verbally than to deliberately falsify data 
by opening MEMS devices without taking medication.35 
MEMS may produce some improvement in adherence and 
of themselves, but this study’s 2-month run-in period helped 
to ensure that any patients who improved their adherence 
due to mere measurement effects were excluded prior to 
the start of the intervention. Nevertheless, unobtrusive 
adherence measures such as pharmacy fill data would 
strengthen further research by eliminating concerns about 
measurement effects.
Attrition was an important limitation to conclusions about 
patients’ receipt and enactment of MI. It is important to note 
that African-American patients were more likely to drop out, 
and also have been found to have lower adherence in previous 
research.11 Based on analyses that included all available data 
from both patients who completed the full intervention and 
those who dropped out, patients increased their motivation 
and adherence while participating in the educator program, 
but this finding requires replication.
Finally, this feasibility study was not designed to prove 
that improvements in adherence were causally related to 
the educator program. Attrition, history effects, maturation, 
regression to the mean, or other artifacts are potential compet-
ing explanations. The current study also was not designed to 
differentiate the specific effects of MI from those that might 
be achieved by mere attention from a glaucoma educator. 
These limitations will be most effectively addressed in 
future work comparing participants’ results to a randomized 
control group.
implications for practice
Glaucoma medications improve long-term outcomes, 
but patients find adherence difficult, and nonadherence 
increases the chance of disease progression. Following the 
lead of other medical specialties, the authors adopted a 
team approach to improve adherence. A glaucoma educator 
supported patients over time using MI. Working with local 
health behavior experts facilitated the integration of MI into 
ophthalmology practice. Although experts in using MI to 
promote   adherence may not be available in all clinical set-
tings, many community-based mental health practitioners 
have expertise in this approach and an interest in integrating 
psychological counseling into medical settings.41 To  iden-
tify mental health professionals with relevant expertise, US 
ophthalmologists can consult online listings at http://www.
findapsychologist.org/ or http://www.therapytribe.com/, or 
find their local community mental health center at http://
mentalhealth.samhsa.gov/databases/.
In this study, MI techniques were successfully learned 
and delivered by a glaucoma educator with no prior training 
in patient counseling methods. Not all practices may be able 
to afford or implement a separate glaucoma educator posi-
tion. Training ophthalmologists themselves to use MI might 
be another option, although one that was not evaluated in 
this study. Some evidence does suggest that ophthalmolo-
gists can learn a more patient-centered counseling style 
and that it improves their ability to detect nonadherence.40 
However, because physician time is more expensive than 
nonphysician time and not all ophthalmologists may want 
to change their counseling style,7,25 feasibility may be 
greater when MI is provided by a separate educator. Patients 
also may be more honest with nonphysician health care 
providers.42
The current study delivered MI only to a subgroup of 
patients selected for poor adherence based on MEMS data 
during a 2-month run-in period. This procedure limits gener-
alizability of the findings to nonadherent glaucoma patients 
only. In general practice, it would be preferable to offer MI 
proactively to all patients prescribed glaucoma medication 
rather than offering support only after nonadherence occurs. 
This is especially true because almost 50% of patients with 
glaucoma are nonadherent,6 and ophthalmologists have dif-
ficulty detecting nonadherence.25
Participants received a moderate dose of MI over 
6 months, although there were some problems with the match 
between counseling strategies and participants’ readiness for 
change. Attrition was also a potential problem, with a sample 
that was selected specifically for nonadherence and a higher 
percentage of African-American than white participants 
leaving the educator intervention early. Nevertheless, all 
participants received an adequate dose of MI based on prior 
meta-analytic findings.14 Furthermore, MI was associated 
with increased readiness for change and improved adher-
ence, and patient counseling in general has a significant 
dose-response effect,43 so multiple patient contacts are still Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
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recommended for MI interventions despite this study’s high 
attrition rate. Overall, MI counseling delivered by a glaucoma 
educator appears to be a feasible adherence intervention in 
ophthalmology practice.
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